References
- Coupland AP, Thapar A, Qureshi MI, Jenkins H, Davies AH. The definition of stroke. J R Soc Med. 2017;110(1):9–12. http://dx.doi.org/10.1177/0141076816680121
- Chugh C. Acute ischemic stroke: Management approach. Indian J Crit Care Med. 2019;23(Suppl 2):S140–6. http://dx.doi.org/10.5005/jp-journals-10071-23192
- Patil S, Rossi R, Jabrah D, Doyle K. Detection, diagnosis and treatment of acute ischemic stroke: Current and future perspectives. Front Med Technol. 2022;4:748949. http://dx.doi.org/10.3389/fmedt.2022.748949
- French BR, Boddepalli RS, Govindarajan R. Acute ischemic stroke: Current status and future directions. Mo Med. 2016;113(6):480–6.
- Akbarzadeh MA, Sanaie S, Kuchaki Rafsanjani M, Hosseini MS. Role of imaging in early diagnosis of acute ischemic stroke: a literature review. Egypt J Neurol Psychiatr Neurosurg. 2021;57(1). http://dx.doi.org/10.1186/s41983-021-00432-y
- El-Koussy M, Schroth G, Brekenfeld C, Arnold M. Imaging of acute ischemic stroke. Eur Neurol. 2014;72(5–6):309–16. http://dx.doi.org/10.1159/000362719
- Sui B, Gao P. Imaging evaluation of acute ischemic stroke. J Int Med Res. 2020;48(1):300060518802530. http://dx.doi.org/10.1177/0300060518802530
- Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses. Arterioscler Thromb Vasc Biol. 2020;40(9):2033–44. http://dx.doi.org/10.1161/ATVBAHA.120.314514
- Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34–45. http://dx.doi.org/10.1038/nri3345
- Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–90. http://dx.doi.org/10.1001/jamaneurol.2020.1127
- Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889–91. http://dx.doi.org/10.1136/jnnp-2020-323586
- Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, et al. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke. 2020;51(7):2219–23. http://dx.doi.org/10.1161/STROKEAHA.120.030365
- Majidi S, Fifi JT, Ladner TR, Lara-Reyna J, Yaeger KA, Yim B, et al. Emergent large vessel occlusion stroke during New York City’s COVID-19 outbreak: Clinical characteristics and paraclinical findings. Stroke. 2020;51(9):2656–63. http://dx.doi.org/10.1161/STROKEAHA.120.030397
- Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and antithrombotic treatment in Coronavirus 2019: A new challenge. Thromb Haemost . 2020;120(6):949–56. http://dx.doi.org/10.1055/s-0040-1710317
- Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GDO, Fowkes FGR. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study: The Edinburgh Artery Study. Circulation . 2007;115(16):2119–27. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.635029
- Kvernland A, Kumar A, Yaghi S, Raz E, Frontera J, Lewis A, et al. Anticoagulation use and hemorrhagic stroke in SARS-CoV-2 patients treated at a New York healthcare system. Neurocrit Care . 2021;34(3):748–59. http://dx.doi.org/10.1007/s12028-020-01077-0
- Sweid A, Hammoud B, Weinberg JH, Oneissi M, Raz E, Shapiro M, et al. Letter: Thrombotic neurovascular disease in COVID-19 patients: Thrombotic neurovascular disease in COVID-19 patients. Neurosurgery. 2020;87(3):E400–6. http://dx.doi.org/10.1093/neuros/nyaa254
- Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of covid-19 in the young. N Engl J Med . 2020;382(20):e60. http://dx.doi.org/10.1056/NEJMc2009787
- de Lorenzo A, Espinel L, Revilla Á, Corbalán T, Martins J, Naya MT, et al. Ischaemic stroke associated with COVID-19 in dialysis patients. Nefrol (Engl Ed) . 2021;41(5):590–3. http://dx.doi.org/10.1016/j.nefroe.2021.11.002
- Ozel T, Erdem N, Ünal A, Yalçın A, İnan D, Ilhanli N, et al. Neurological manifestations and mortality in hospitalized coronavirus disease 2019 patients. Neurol Sci Neurophysiol. 2022;39(3):138. http://dx.doi.org/10.4103/nsn.nsn_117_21
- Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8. http://dx.doi.org/10.1093/cid/ciaa248
- Steardo L, Steardo L Jr, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) . 2020;229(3):e13473. http://dx.doi.org/10.1111/apha.13473
- Xia H, Sriramula S, Chhabra KH, Lazartigues E. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ Res. 2013;113(9):1087–96. http://dx.doi.org/10.1161/CIRCRESAHA.113.3018
- Fraga-Silva RA, Da Silva DG, Montecucco F, Mach F, Stergiopulos N, da Silva RF, et al. The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases. Thromb Haemost . 2012;108(6):1089–96. http://dx.doi.org/10.1160/TH12-06-0396
- Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50(3):499–511. http://dx.doi.org/10.1007/s11239-020-02230-4
- Takasu S, Ariizumi M, Matsumoto S, Nakagawa H, Iwadate K. Cerebral venous sinus thrombosis associated with COVID-19: an autopsy case report. Forensic Sci Med Pathol . 2022;18(1):80–5. http://dx.doi.org/10.1007/s12024-022-00458-5
- Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. COVID-19 is an independent risk factor for acute ischemic stroke. AJNR Am J Neuroradiol . 2020;41(8):1361–4. http://dx.doi.org/10.3174/ajnr.A6650
- Yang XH, Deng W, Tong Z, Liu YX, Zhang LF, Zhu H, et al. Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp Med. 2007;57(5):450–9.
- Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol . 2008;82(15):7264–75. http://dx.doi.org/10.1128/JVI.00737-08
- Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995–8. http://dx.doi.org/10.1021/acschemneuro.0c00122
- Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun . 2020;11(1). http://dx.doi.org/10.1038/s41467-020-18319-6
- Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002–11. http://dx.doi.org/10.1161/STROKEAHA.120.030335
- Siegler JE, Cardona P, Arenillas JF, Talavera B, Guillen AN, Chavarría-Miranda A, et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. Int J Stroke . 2021;16(4):437–47. http://dx.doi.org/10.1177/1747493020959216
- Cavallieri F, Marti A, Fasano A, Dalla Salda A, Ghirarduzzi A, Moratti C, et al. Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: A dangerous association. eNeurologicalSci . 2020;20(100247):100247. http://dx.doi.org/10.1016/j.ensci.2020.100247
- Morey JR, Kim BD, Redlener M, Zhang X, Marayati NF, Matsoukas S, et al. Updated New York city emergency medical services acute stroke triage protocol reduces interfacility transfers and time to endovascular thrombectomy for emergent large vessel occlusion stroke patients. J Stroke . 2022;24(3):417–20. http://dx.doi.org/10.5853/jos.2022.01200
- Rudilosso S, Laredo C, Vera V, Vargas M, Renú A, Llull L, et al. Acute stroke care is at risk in the era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona: Experience at a Comprehensive Stroke Center in Barcelona. Stroke . 2020;51(7):1991–5. http://dx.doi.org/10.1161/STROKEAHA.120.030329
- White TG, Martinez G, Wang J, Gribko M, Boltyenkov A, Arora R, et al. Impact of the COVID-19 pandemic on acute ischemic stroke presentation, treatment, and outcomes. Stroke Res Treat . 2021;2021:8653396. http://dx.doi.org/10.1155/2021/8653396
- Zaaqoq AM, Griffee MJ, Kelly TL, Fanning J, Heinsar S, Suen J, et al. Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation. Research Square. 2022. http://dx.doi.org/10.21203/rs.3.rs-1785832/v1
- Kihira S, Schefflein J, Mahmoudi K, Rigney B, N Delman B, Mocco J, et al. Association of Coronavirus disease (COVID-19) with large vessel occlusion strokes: A case-control study. AJR Am J Roentgenol. 2021;216(1):150–6. http://dx.doi.org/10.2214/AJR.20.23847
- Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: A systematic review and meta-analysis: A systematic review and meta-analysis. Stroke. 2018;49(4):814–9. http://dx.doi.org/10.1161/STROKEAHA.117.020031
- Morassi M, Bagatto D, Cobelli M, D’Agostini S, Gigli GL, Bnà C, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol . 2020;267(8):2185–92. http://dx.doi.org/10.1007/s00415-020-09885-2
- Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis . 2020;50(3):587–95. http://dx.doi.org/10.1007/s11239-020-02228-y
- John S, Kesav P, Mifsud VA, Piechowski-Jozwiak B, Dibu J, Bayrlee A, et al. Characteristics of large-vessel occlusion associated with COVID-19 and ischemic stroke. AJNR Am J Neuroradiol . 2020;41(12):2263–8. http://dx.doi.org/10.3174/ajnr.A6799
- Amiri HA, Razavi AS, Tabrizi N, Cheraghmakani H, Baghbanian SM, Sedaghat-Chaijan M, et al. The effects of COVID-19 on patients with acute ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis. 2022;31(7):106512. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2022.106512
- Sojka M, Drelich-Zbroja A, Kuczyńska M, Cheda M, Dąbrowska I, Kopyto E, et al. Ischemic and hemorrhagic cerebrovascular events related to COVID-19 coagulopathy and hypoxemia. Int J Environ Res Public Health. 2022;19(18):11823. http://dx.doi.org/10.3390/ijerph191811823
- Hurley D. Sharp increase in large-vessel stroke risk seen in young, healthy COVID-19 patients. Neurol Today. 2020;20(10):36–7. http://dx.doi.org/10.1097/01.nt.0000668912.81159.e3
- Cascio Rizzo A, Giussani G, Agostoni EC. Ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia following COVID-19 vaccine: A case report with systematic review of the literature. Cerebrovasc Dis. 2022;51(6):722–34. http://dx.doi.org/10.1159/000524290
- Trepet G, Radzikhovska N. Ischemic Stroke in COVID-19: A Systematic Review. J Pharm Res Int. 2021;2412–20. http://dx.doi.org/10.9734/jpri/2021/v33i60b34893
- Dixon L, Coughlan C, Karunaratne K, Gorgoraptis N, Varley J, Husselbee J, et al. Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology. J Neurol Neurosurg Psychiatry . 2020;92(1):103–4. http://dx.doi.org/10.1136/jnnp-2020-324291
- Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA, Collado-Jiménez R, Ayo-Martín Ó, Barrena C, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain . 2020;143(10):3089–103. http://dx.doi.org/10.1093/brain/awaa239
- Lapergue B, Lyoubi A, Meseguer E, Avram I, Denier C, Venditti L, et al. Large vessel stroke in six patients following SARSCoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease. Eur J Neurol . 2020;27(11):2308–11. http://dx.doi.org/10.1111/ene.14466
- McAlpine LS, Zubair AS, Maran I, Chojecka P, Lleva P, Jasne AS, et al. Ischemic stroke, inflammation, and endotheliopathy in COVID-19 patients. Stroke . 2021;52(6):e233–8. http://dx.doi.org/10.1161/STROKEAHA.120.031971
- Katz JM, Libman RB, Wang JJ, Sanelli P, Filippi CG, Gribko M, et al. Cerebrovascular complications of COVID-19. Stroke . 2020;51(9):e227–31. http://dx.doi.org/10.1161/STROKEAHA.120.031265
- Cappellari M, Zini A, Sangalli D, Cavallini A, Reggiani M, Sepe FN, et al. Thrombolysis and bridging therapy in patients with acute ischaemic stroke and Covid-19. Eur J Neurol. 2020;27(12):2641–5. http://dx.doi.org/10.1111/ene.14511
- Salahuddin H, Afreen E, Sheikh IS, Lateef S, Dawod G, Daboul J, et al. Neurological predictors of clinical outcomes in hospitalized patients with COVID-19. Front Neurol . 2020;11:585944. http://dx.doi.org/10.3389/fneur.2020.585944